Citigroup Inc Acorda Therapeutics Inc Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.52 - $0.77 $565 - $836	-1,087 Reduced 75.38%	355 $0
Q3 2022 Nov 10, 2022	BUY	$0.29 - $0.53 $418 - $764	1,442 New	1,442 $0
Q2 2022 Aug 10, 2022	SELL	$0.3 - $1.67 $497 - $2,768	-1,658 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.61 - $2.5 $2,669 - $4,145	1,658 New	1,658 $3,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.